Leishmania infection and virulence

Medical Microbiology and Immunology

Volumn 190, Issue 1-2, 2001, Pages 37-42

  Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; GLYCOPROTEIN; LIPOPHOSPHOGLYCAN; PROTEIN; PROTEIN A2; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANALYTIC METHOD; ARTICLE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA TROPICA; LEISHMANIASIS; LIFE CYCLE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE SURVIVAL; PARASITE VIRULENCE; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN FAMILY;

EID: 0035175727     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004300100076     Document Type: Article

References (65)

1. Estimation of population at risk of infection and number of cases of Leishmaniasis
2. Leishmaniasis
3. Leishmaniasis
4. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
5. Clinical spectrum of leishmaniasis
6. Development of infective stage Leishmania promastigotes within phlebotomine sandflies
7. Stage-specific binding of Leishmania donovani to the sandfly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglygan
8. Exploitation of the complement systems by Leishmania promastigotes
9. Evidence that Leishmania donovani utilises a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism
10. Leishmania donovani macrophage binding mediated by surface glycoproteins/antigens
11. The major surface protein of Leishmania promastigotes in a fibronectin-like molecule
12. Lipophosphoglycan (LPG) of Leishmania mexicana promastigotes bind to the CR3, p150/95, and LFA-1 family of leukocyte integrins
13. The vasoactive peptide maxadilan from sandfly saliva inhibits TNF and induces IL-6 by mouse macrophages through interaction with the PACAP receptor
14. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages
15. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes
16. Parasite accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products
17. Modulation of in vivo monocyte cytokine responses to Leishmania donovani. Interferon-γ presents parasite-induced inhibition of interleukin I production and prime tumour necrosis factor and interleukin I
18. Analysis of cytokine production by inflammatory mouse macrophages at the single cell level: Selective impairment of IL-12 induction in Leishmania infected cells
19. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages
20. Inhibition of macrophage protein kinase C mediated protein phosphorylation by Leishmania donovani lipophosphoglycan
21. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction
22. Modulation of interferon-γ induced macrophage activation by phosphotyrosine phosphatase inhibition. Effect on murine leishmaniasis progression
23. c-fos and tumour necrosis factor gene expression in Leishmania donovani-infected macrophages
24. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp.
25. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation of protein kinase C
26. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis
27. Inhibition of phagolysosomal biogenesis by Leishmania lipophosphoglycan
28. Neutralisation of IL-12 demonstrates the existence of discrete organ specific phases in the control of Leishmania donovani
29. Recombinant interleukin-12 cures mice infected with Leishmania major
30. Endogenous IL-12 is required for control of TH2 cytokine responses capable of exacerbating leishmaniasis in normal resistant mice
31. Switch from type 2 to type 1 T-helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam
32. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis
33. Lipophosphoglycan (LPG) and identification of virulence genes in protozoan parasite Leishmania
34. The lipophosphoglycan of Leishmania parasites
35. Requirement of lipophosphoglycan for intracellular survival of leishmania donovani within human monocytes
36. A specialized pathway affecting virulence glycoconjugates of Leishmania
37. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major
38. Expression of LPG and GP63 by different developmental stages of Leishmania major in the sandfly Phlebotomus papatasi
39. The role of phosphoglycans in Leishmaniasand fly interactions
40. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana
41. Developmental gene expression in Leishmania donovani: Differential cloning and analysis of an amastigote stage-specific gene
42. The developmental expression of leishmania donovani A2 amastigote specific genes is post-transcriptionally mediated and involves elements located in the 3'UTR
43. Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani
44. Antibody response against a Leishmania donovani amastigote specific protein in patients with visceral leishmaniasis
45. Protection against Leishmania donovani infection by DNA vaccination: Increased DNA vaccination efficiency through inhibiting the cellular p53 response
46. Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2
47. Characterization of the A2-A2rel gene cluster in Leishmania donovani: Involvement of A2 in visceralization during infection
48. Leishmania donovani heat shock protein 100: Characterization and function in amastigote stage differentiation
49. A developmentally regulated cysteine proteinase gene of Leishmania mexicana
50. Cathepsin B-like cysteine proteinase deficient mutants of Leishmania mexicana
51. Null mutants for the lmcp cysteine proteinase gene in Leishmania mexicana
52. Evidence from disruption of the lmcpb gene array of Leishmania mexicana mexicana that cysteine proteinases are virulence factors
53. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Thl response
54. Organ-specific immune responses associated with infectious disease
55. Biology of the Leishmania surface: With particular reference to the surface proteinase, gp63
56. Surface Zn-protease as a molecular defense of Leishmania mexicana amazonensis promastigote against cytolysis inside macrophage phagolysosomes
57. Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages
58. Role of Leishmania surface protease gp63 in complement fixation, cell adhesion and resistance to complement-mediated lysis
59. Exploitation of the complement system by Leishmania promastigotes
60. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region on the major surface glycoprotein, gp63, of Leishmania promastigotes
61. Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes
62. Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages
63. Genetic rescue of surface metalloproteinase (gp63)-deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase
64. Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: Modulation of gp63 level in promastigotes and their infection of macrophages in vitro
65. Genomics of the biology of parasites